ipsc derived cardiomyocytes for predicting and removing drug cardiotoxicity - mark mercola
Published 3 years ago • 898 plays • Length 14:16Download video MP4
Download video MP3
Similar videos
-
1:17:40
cardiac stem cells - anthony demaria, deepak srivistava, mark mercola, deborah lieu
-
1:17:21
investigative in vitro drug toxicology with human ipsc derived cardiomyocytes
-
2:01
human ipsc-derived cardiomyocytes, cardiac fibroblasts, & endothelial cells l protocol preview
-
51:40
heart disease in a dish: human ipsc-derived multicellular cardiac organoids
-
36:16
ipscs for cardiovascular diseases
-
16:43
stem cells - the future: an introduction to ips cells
-
2:35
how serrapeptase enzymes works in your body for overall health
-
58:50
myeloid cells and cardiovascular health
-
42:06
cardiac proarrhythmic risk assessment using human ipsc-derived cardiomyocytes - session 2
-
0:06
ipsc-derived cardiac cells beat
-
40:14
using patient specific ipsc-cardiomyocytes for disease modeling
-
1:01:00
predictive human induced pluripotent stem cell-derived cardiomyocyte model of cardiotoxicity
-
0:28
induction of human ipsc-derived cardiomyocyte proliferation revealed by combinatorial screening
-
0:08
ipsc-derived cardiomyocytes | applied stemcell, inc.
-
2:01
cardiomyocytes and progenitors generated from stem cells | protocol preview
-
2:01
ipsc derived cells contractions measured with ca-fluorescent dye | protool preview
-
53:40
utilizing stem cell-derived cardiomyocytes for early safety screening - webinar presentation
-
57:01
exploring the role of ipsc-cardiomyocytes in drug discovery and safety assessment
-
0:16
heart cells derived from ipsc stem cells beat in culture dish
-
49:26
harnessing ipsc-derived cardiac progenitor cells and fibroblasts for myocardial repair